Innovative AI Solutions Quibim specializes in developing AI-powered imaging biomarkers and tools for medical imaging, presenting opportunities to partner with healthcare providers seeking advanced diagnostic solutions for conditions like prostate, liver, and lung diseases.

Recent Expansion & Funding With a recent $50M Series A financing and efforts to establish a presence in the US, Quibim is positioned for growth, making it a promising partner for hospitals, research institutions, and health systems aiming to incorporate cutting-edge AI imaging technology.

Strategic Partnerships Collaborations with notable companies like Aidoc and NVIDIA MONAI highlight Quibim’s focus on democratizing AI in healthcare, opening avenues for joint ventures, integrations, and shared technology platforms with potential clients in the medical imaging ecosystem.

Product Portfolio Expansion Recent launches such as AI-QUAL and QP-Liver demonstrate Quibim’s commitment to addressing diverse diagnostic needs, creating opportunities to upsell or tailor solutions for institutions focused on prostate, liver, or lung disease detection and management.

Global Market Potential Based in Spain with ambitions for US expansion, Quibim’s scalable AI solutions are well-suited for international healthcare providers seeking innovative, non-invasive diagnostic tools, making it a valuable partner for global market penetration.